← Back to headlines
Indian Drugmaker Granules to Tighten Oversight After US FDA Warning
Indian drugmaker Granules plans to tighten its oversight processes after receiving a warning from the US FDA, according to an executive.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Philippine Pharma Companies Reaffirm Medicine Price Freeze Until June Amid Middle East Crisis
just now
Philippine National Oil Co. Seeks P8-B Fuel Budget for Reserves
just now
Meralco Increases Power Rates for Third Consecutive Month Amid Middle East Conflict
just now